Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Royalty Pharma has entered into a funding agreement with Zealand Pharma, providing $100 million in exchange for economic rights to rusfertide, a potential first-in-class therapy for polycythemia vera. The funding supports Zealand Pharma's pipeline and accelerates the drug's progression through regulatory review, with a US FDA decision expected in Q…
Gaxos.ai Inc. announced record second-quarter revenue of $2.46 million, a 35.8% sequential increase and a 1,337% year-over-year surge. The company improved its marketing efficiency by increasing revenue generated per advertising dollar by approximately 20%. Gaxos completed the sale of its gaming assets, focusing on AI applications in consumer and e…
John B. Sanfilippo & Son, Inc., a leading processor and distributor of snack and recipe nut products, will release its fourth quarter fiscal 2026 operating results after the market close on August 19, 2026, followed by a conference call on August 20, 2026 at 10:00 a.m. ET to discuss the results. The company operates multiple nut and dried fruit sna…
Toppoint Holdings Inc. reported a 17% year-over-year revenue increase to $4.6 million in Q2 2026, an 80% reduction in net loss to $306,711, and a return to positive gross margin of 8%, driven by a strategic shift toward higher-value import and metal loads and price increases. The company completed a $4.15 million private placement, strengthened its…
Cognex (CGNX) is a profitable, cash-generative machine vision leader that the market appears to be discounting relative to its exposure to AI-driven data center and semiconductor supply chains. Strong margins, zero financial debt, and $268M in free cash flow underpin a long-term trade with a favorable risk-reward.
MaxCyte, Inc. reported Q2 2026 total revenue of $7.3 million, with a net loss of $8.9 million, showing improvement from the prior year. The company reiterated its full-year 2026 revenue guidance of $30-32 million and highlighted a strategic multi-platform technology license partnership with Genentech announced post-quarter. Operating expenses decre…
Aligos Therapeutics announced the successful dosing of the first participant in the Phase 1 clinical trial of ALG-170675, a next-generation antisense oligonucleotide aimed at functional cure for chronic hepatitis B virus infection. The study is being conducted in China by their partner Amoytop, who holds rights in Greater China. ALG-170675 has demo…
Acrivon Therapeutics, a clinical-stage biotech company, announced its Q2 2026 financial results, highlighted progress in its lead clinical programs ACR-368 and ACR-2316 targeting endometrial and lung cancers, respectively, and provided upcoming milestones including interim data readouts and initiation of Phase 3 trials. The company also strengthene…
Connect Biopharma Holdings Limited reported financial results for Q2 2026, highlighted by completion of enrollment in Phase 2 Seabreeze STAT trials assessing rademikibart for acute exacerbations in asthma and COPD. Topline data are expected in September 2026, which will inform potential Phase 3 trial design. The company has a cash runway of at leas…
Core Molding Technologies, a leading engineered materials company specializing in molded structural products for various industries, announced an investor day event on September 29-30, 2026, including presentations and a tour of its large manufacturing facility in Matamoros, Mexico. Management will discuss growth opportunities, operational excellen…
Enovix Corporation reported Q2 2026 revenue of $9 million, up 21% year-over-year and at the high end of guidance, marking five consecutive quarters of growth. The company achieved its seventh consecutive quarter of positive gross profit amid increasing production scale. Key milestones include the lead smartphone customer confirming 1000+ battery cy…
Longeveron Inc. reported its Q2 2026 financial results and provided updates on its stem cell therapy programs targeting rare pediatric diseases and aging-related conditions. The company remains on track to release top-line Phase 2b trial results for its HLHS treatment in September 2026, received significant FDA designations across several indicatio…
Forward Industries, a NASDAQ-listed Solana-focused digital asset treasury company, reported strong operational growth in Q3 fiscal 2026 with a 4x increase in revenue driven by staking and treasury activities. The company expanded its Solana (SOL) holdings significantly, repurchased shares to enhance value, and was included in the Russell 2000 and 3…
NANO Nuclear Energy Inc. reported its Q3 FY 2026 financial results with key milestones including NRC acceptance of its KRONOS MMR Energy System construction permit application, acquisition of Secured Transportation Systems to enhance vertical integration, completion of a 1 GW feasibility study for data center projects, and a strong cash position of…
ITG, Inc., a leading provider of digital infrastructure services, reported a 38% year-over-year revenue increase to $404.6 million and a 21% increase in adjusted EBITDA for Q2 2026. The company completed its IPO after the quarter and raised net proceeds mainly for debt repayment. ITG's substantial backlog and strong order activity, including broadb…
Lumexa Imaging announced its second quarter 2026 financial results, showing a 5.1% increase in consolidated revenues to $264.2 million and achieving net income of $2.7 million compared to a loss the previous year. The company highlighted advances including the opening of four new imaging centers and a new joint venture with Hospital for Special Sur…
SKYX Platforms Corp. announced strong Q2 2026 financial results with record sales of $25.3 million, representing 14% growth from Q1 2026 and 10 consecutive quarters of year-over-year revenue growth. The company improved gross profit and reduced net losses, supported by a better cash position of $27.7 million enabling plans to reach cash flow positi…
Byrna Technologies Inc., a Nasdaq-listed personal defense technology company, announced the appointment of retired U.S. Army Brigadier General Rose Lopez Keravuori to its Board of Directors, effective August 10, 2026. Keravuori brings over 30 years of strategic leadership and risk management experience, enhancing Byrna's governance as the company p…
SeaStar Medical announced strong second quarter 2026 financial results, highlighted by an 82% increase in net revenue from its QUELIMMUNE pediatric acute kidney injury (AKI) therapy compared to Q2 2025. The company expanded its pediatric customer base, progressed enrollment in its pivotal NEUTRALIZE-AKI clinical trial targeting adult AKI patients, …
Coherent Corp., a leading global photonics company, reported its fiscal Q4 2026 and full year results with a 34% year-over-year revenue increase to $2.05 billion for Q4 and $7.12 billion for the full year. The company achieved significant margin expansion, with GAAP gross margin increasing by 277 basis points year-over-year to 38.5%, and GAAP EPS g…
OptimizeRx Corp., a leading healthcare technology company, announced that Andy D'Silva will succeed Ed Stelmakh as Chief Financial Officer and Heather Favazza will become Chief Accounting Officer starting January 1, 2027. The transition underscores the company's disciplined succession planning and strong finance leadership bench. Ed Stelmakh will c…
Crown Crafts, Inc. reported a strong start to fiscal 2027 with net sales rising to $16.8 million from $15.5 million in the previous year quarter, driven by higher demand and tariff refunds. The company achieved a gross profit margin of 47.9%, notably boosted by $3.7 million in tariff refunds, and posted a net income of $2.1 million compared to a ne…
Atea Pharmaceuticals reported positive Phase 3 C-BEYOND trial results for its HCV treatment regimen BEM/RZR, demonstrating statistical non-inferiority to the current standard of care with a shorter 8-week treatment for non-cirrhotic patients. The company continues to advance its C-FORWARD trial outside North America with topline results expected in…
Nortech Systems Incorporated reported Q2 2026 financial results with a 9.3% increase in net sales year-over-year to $33.5 million and a slight increase in net income to $316,000. Adjusted EBITDA declined modestly by 12.6%, while the company's backlog grew 20% to $93.8 million, indicating strong future demand. Management highlights improved gross ma…
Perma-Fix Environmental Services announced its second quarter 2026 financial results, highlighting operational milestones including commencement of waste receipts from the Direct-Feed Low-Activity Waste (DFLAW) facility and awarding of a Master IDIQ Subcontract for Hanford mixed low-level waste treatment and disposal. Despite operational progress, …
